Bloomios Stock Today
| BLMS Stock | USD 0.0001 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressLow
|
Bloomios is selling for under 1.0E-4 as of the 27th of January 2026; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Bloomios has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 29th of October 2025 and ending today, the 27th of January 2026. Click here to learn more.
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. Bloomios is traded on OTC Exchange in the United States. The company has 14.25 M outstanding shares. More on Bloomios
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bloomios Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Bloomios [BLMS] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bloomios's market, we take the total number of its shares issued and multiply it by Bloomios's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bloomios conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 14.25 M outstanding shares.
Bloomios currently holds about 64 K in cash with (98.52 K) of positive cash flow from operations.
Check Bloomios Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Bloomios is $14.39 Million. Bloomios shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 79.55 percent of Bloomios outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Bloomios Ownership Details
Bloomios Stock Against Markets
Bloomios Pink Sheet Analysis Notes
About 80.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.13. Bloomios had not issued any dividends in recent years. The entity had 1:50 split on the 11th of December 2006. Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. Bloomios is traded on OTC Exchange in the United States.The quote for Bloomios is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bloomios please contact Michael Hill at 805 222 6330 or go to https://www.bloomios.com.Bloomios Investment Alerts
| Bloomios generated a negative expected return over the last 90 days | |
| Bloomios has some characteristics of a very speculative penny stock | |
| Bloomios currently holds 150 K in liabilities. Bloomios has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bloomios until it has trouble settling it off, either with new capital or with free cash flow. So, Bloomios' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bloomios sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bloomios to invest in growth at high rates of return. When we think about Bloomios' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.49 M. Net Loss for the year was (2.01 M) with profit before overhead, payroll, taxes, and interest of 3.78 M. | |
| Bloomios currently holds about 64 K in cash with (98.52 K) of positive cash flow from operations. | |
| Roughly 80.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: OpenAI Would Like You to Share Your Health Data with Its ChatGPT - Scientific American |
Bloomios Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bloomios's market, we take the total number of its shares issued and multiply it by Bloomios's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Bloomios Profitablity
The company has Profit Margin (PM) of (0.91) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.76.Technical Drivers
Bloomios technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bloomios Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bloomios Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Bloomios price patterns.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bloomios without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Additional Tools for Bloomios Pink Sheet Analysis
When running Bloomios' price analysis, check to measure Bloomios' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomios is operating at the current time. Most of Bloomios' value examination focuses on studying past and present price action to predict the probability of Bloomios' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomios' price. Additionally, you may evaluate how the addition of Bloomios to your portfolios can decrease your overall portfolio volatility.